文献速递细菌感染、耐药与抗菌药物艾滋病与性传播感染

西班牙淋病奈瑟菌抗菌药物耐药性前瞻性多中心研究

Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study.
PubMed 文献 · J Antimicrob Chemother · 2021-01-01

该研究在2018年4月至2019年9月期间从西班牙10家医院收集2571株淋病奈瑟菌,测定多种抗菌药物的MIC并分析耐药决定因素。结果显示头孢曲松耐药率低(0.2%),但阿奇霉素耐药率为12.1%且地区差异大,环丙沙星耐药率达56.2%。研究提示西班牙淋球菌对广谱头孢菌素敏感性仍高,但阿奇霉素耐药率质疑双疗法的适用性。

要点

  • 头孢曲松耐药率仅0.2%,头孢克肟耐药率1.7%。
  • 阿奇霉素总耐药率12.1%,地区差异大,质疑双疗法适用性。
  • 环丙沙星耐药率高达56.2%,提示应避免使用。

核心结论

  • 西班牙淋球菌对广谱头孢菌素敏感性仍高,但阿奇霉素耐药率质疑双疗法适用性。
  • 研究为更新国家治疗指南提供数据,并强调建立国家淋球菌耐药监测规划的必要性。

研究设计与样本

  • 前瞻性观察性研究,2018年4月1日至2019年9月30日从西班牙8个地区10家医院收集淋球菌分离株。
  • 对2571株淋球菌(来自2429例患者)用Etest测定青霉素、头孢克肟、头孢曲松、阿奇霉素、环丙沙星、磷霉素和庆大霉素的MIC。
  • 使用逻辑回归分析鉴定耐药决定因素,P值<0.05认为有统计学显著性。

主要发现

  • 44.5%(945/2124)患者为MSM。
  • 对广谱头孢菌素耐药率低:头孢曲松耐药0.2%(6/2561),头孢克肟耐药1.7%(44/2517)。
  • 阿奇霉素总耐药率12.1%(310/2560),但不同地区差异很大。
  • 环丙沙星耐药菌株占56.2%(1366/2429)。
  • 庆大霉素MIC50和MIC90分别为4和8 mg/L;磷霉素MIC50和MIC90分别为24和48 mg/L。

临床怎么用

  • 在西班牙,广谱头孢菌素仍可作为淋病治疗的有效选择。
  • 阿奇霉素耐药率较高且地区差异大,应重新评估双疗法中阿奇霉素的适用性。
  • 环丙沙星耐药率超过50%,不应作为经验性治疗药物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Gonococcal infection is one of the most reported sexually transmitted infections and antimicrobial resistance in Neisseria gonorrhoeae (NG) is challenging for the treatment of this infection. This observational study aimed to describe antimicrobial resistance of NG and epidemiological data from patients with gonococcal infection in eight regions of Spain, for updating the local therapeutic guidelines. METHODS: MICs of penicillin, cefixime, ceftriaxone, azithromycin, ciprofloxacin, fosfomycin and gentamicin were determined by Etest for all NG isolates recovered from 1 April 2018 to 30 September 2019 from 10 hospitals in Spain. Resistance determinants were identified using logistic regression analysis. Differences with a P value <0.05 were considered statistically significant. RESULTS: Antimicrobial susceptibility testing was performed for 2571 gonococci isolated from 2429 patients. 44.5% (945/2124) of patients were MSM. The resistance rate to extended-spectrum cephalosporins was low, with 0.2% (6/2561) of isolates resistant to ceftriaxone and 1.7% (44/2517) of isolates resistant to cefixime. The overall azithromycin resistance rate was 12.1% (310/2560), but differed greatly depending on the area. 56.2% (1366/2429) of the strains studied were ciprofloxacin resistant. MIC50 and MIC90 values of gentamicin and fosfomycin were 4 and 8 mg/L and 24 and 48 mg/L, respectively. CONCLUSIONS: Our study shows that NG susceptibility to extended-spectrum cephalosporins remains high in Spain. The azithromycin resistance rate questions the suitability of dual therapy. This study provides data of interest for updating the national treatment guidelines and highlights the need to develop and implement a national sentinel gonococcal antimicrobial susceptibility programme.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Salmerón P, Viñado B, Arando M, et al. Neisseria gonorrhoeae antimicrobial resistance in Spain: a prospective multicentre study. J Antimicrob Chemother. 2021. PMID: 33569588. doi:10.1093/jac/dkab037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。